Clinical Approach to Fatigue
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of fatigue
Fatigue is one of the most common presenting complaints in primary care, accounting for approximately 5 to 10% of all physician visits. Studies indicate that up to 25% of adults report experiencing significant fatigue at any given time, with prevalence rates higher in women than men. Despite its ubiquity, fatigue remains one of the most diagnostically challenging symptoms due to its subjective nature and the vast array of potential underlying causes. Only about 5% of cases presenting with fatigue will have a serious underlying medical condition, yet the symptom profoundly impacts quality of life, work productivity, and daily functioning.
Definition
Fatigue is a subjective sensation of persistent tiredness, exhaustion, or lack of energy that is not relieved by rest and interferes with usual activities. It is distinct from drowsiness (desire to sleep), dyspnea on exertion (breathlessness), and muscle weakness (objective loss of strength). True fatigue represents a global sense of decreased capacity for physical and mental activity that is disproportionate to recent exertion.
Key Epidemiology
- Primary care visits: 5 to 10% of all consultations
- Population prevalence: 20 to 25% of adults report persistent fatigue
- Gender distribution: 1.5 to 2 times more common in women
- Organic cause identified: Approximately 40 to 50% of cases
- Psychiatric cause identified: Approximately 30 to 40% of cases
- Unexplained after workup: Approximately 20 to 30% of cases
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute Fatigue | Less than 1 month | Viral infections, acute stress, sleep deprivation, medication side effects, early pregnancy | Usually self-limiting; often related to identifiable precipitant; rarely requires extensive workup |
| Subacute Fatigue | 1 to 6 months | Post-viral syndrome, depression, anemia, thyroid disorders, early malignancy | Warrants systematic evaluation; higher likelihood of identifiable organic or psychiatric cause |
| Chronic Fatigue | Greater than 6 months | Depression, chronic disease, sleep disorders, myalgic encephalomyelitis/chronic fatigue syndrome, fibromyalgia | Requires comprehensive workup; consider multifactorial etiology; may require specialist referral |
Classification by Character
Physical Fatigue
Description: Predominantly affects physical capacity; patients describe muscle tiredness, weakness, or inability to sustain physical activity.
Clinical implications: Suggests neuromuscular disorders, anemia, cardiopulmonary disease, malignancy, or metabolic derangements. Often associated with measurable decline in functional capacity.
Mental Fatigue
Description: Predominantly cognitive; patients describe difficulty concentrating, mental fog, poor memory, or inability to sustain mental effort.
Clinical implications: Strongly associated with psychiatric conditions (depression, anxiety), sleep disorders, and myalgic encephalomyelitis/chronic fatigue syndrome. May also indicate early neurodegenerative disease.
Central Fatigue
Description: Originates from central nervous system dysfunction; difficulty initiating and sustaining voluntary activity despite intact peripheral mechanisms.
Clinical implications: Associated with multiple sclerosis, Parkinson disease, depression, and myalgic encephalomyelitis/chronic fatigue syndrome. Often accompanied by mood disturbance.
Peripheral Fatigue
Description: Originates from dysfunction at or distal to the neuromuscular junction; true muscle fatigability with reduced force generation.
Clinical implications: Suggests myopathies, neuropathies, neuromuscular junction disorders (myasthenia gravis), or metabolic muscle disease. Often demonstrable on examination.
Classification by Pattern and Timing
| Pattern | Description | Suggests |
|---|---|---|
| Morning predominant | Worst upon awakening, may improve as day progresses | Depression, sleep disorders (obstructive sleep apnea), inflammatory arthritis, adrenal insufficiency |
| Afternoon predominant | Develops or worsens as the day progresses | Myasthenia gravis, sleep deprivation, anemia, hypoglycemia |
| Post-exertional | Disproportionate exhaustion following physical or mental activity, often delayed 24 to 72 hours | Myalgic encephalomyelitis/chronic fatigue syndrome (hallmark feature), cardiac disease, pulmonary disease |
| Constant and unremitting | Present throughout the day without significant fluctuation | Malignancy, chronic infection, severe depression, advanced chronic disease |
| Episodic or fluctuating | Comes and goes, may have identifiable triggers | Autoimmune disease (lupus), migraine, anxiety disorders, medication effects |
| Situational | Present only in specific contexts (work, home) | Psychosocial stressors, burnout, depression, anxiety, occupational exposures |
The “Big Five” Causes of Chronic Fatigue: In primary care settings, five categories account for the majority of chronic fatigue presentations:
- Psychiatric disorders — depression, anxiety, somatization (30 to 40%)
- Sleep disorders — obstructive sleep apnea, insomnia, restless legs syndrome (15 to 25%)
- Lifestyle factors — physical inactivity, obesity, poor sleep hygiene, substance use (10 to 20%)
- Medications — beta-blockers, antihistamines, benzodiazepines, opioids (5 to 10%)
- Medical conditions — anemia, thyroid disease, diabetes, chronic infections (15 to 20%)
Impact on Quality of Life
| Domain | Impact | Clinical Relevance |
|---|---|---|
| Occupational | Reduced productivity, absenteeism, job loss, disability claims | Fatigue is a leading cause of workplace disability; assess occupational functioning |
| Social | Social withdrawal, relationship strain, inability to fulfill family roles | Social isolation may perpetuate fatigue; assess support systems |
| Physical | Reduced exercise tolerance, deconditioning, increased fall risk | Physical deconditioning worsens fatigue; assess baseline activity level |
| Psychological | Frustration, loss of identity, depression, anxiety | Bidirectional relationship with mood; screen for psychiatric comorbidity |
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of fatigue
Fatigue is a complex symptom arising from disruption of multiple interconnected physiological systems. Unlike many symptoms with discrete pathways, fatigue results from perturbations in energy metabolism, neurotransmitter signaling, hypothalamic-pituitary-adrenal axis function, immune regulation, and circadian rhythms. Understanding these mechanisms helps explain why fatigue accompanies such diverse conditions and guides rational diagnostic and therapeutic approaches.
Central Regulatory Systems
| System | Normal Function | Role in Fatigue |
|---|---|---|
| Hypothalamus | Integrates autonomic, endocrine, and behavioral responses; regulates sleep-wake cycles | Dysfunction leads to impaired arousal, temperature dysregulation, and hormonal imbalances |
| Reticular activating system | Maintains wakefulness and alertness through ascending projections to cortex | Reduced activation causes decreased alertness and difficulty sustaining attention |
| Basal ganglia | Modulates motivation, effort perception, and motor initiation | Dysfunction impairs sense of effort and motivation; seen in Parkinson disease and depression |
| Prefrontal cortex | Executive function, sustained attention, cognitive effort allocation | Reduced activity leads to mental fatigue, poor concentration, and cognitive fog |
Neurotransmitter Systems and Fatigue
Dopamine
Normal function: Reward, motivation, motor initiation, arousal
Depletion causes: Amotivation, anhedonia, psychomotor slowing, mental fog
Clinical relevance: Implicated in depression, Parkinson disease, and stimulant withdrawal; target for pharmacotherapy
Serotonin
Normal function: Mood regulation, sleep-wake cycling, appetite, pain modulation
Imbalance causes: Mood disturbance, sleep disruption, altered pain perception
Clinical relevance: Central to depression and fibromyalgia; target of selective serotonin reuptake inhibitors
Norepinephrine
Normal function: Alertness, attention, sympathetic activation, stress response
Depletion causes: Decreased arousal, poor concentration, reduced vigilance
Clinical relevance: Implicated in depression and attention deficit disorders; target of serotonin-norepinephrine reuptake inhibitors
Energy Metabolism Pathways
| Pathway | Key Components | Disruption Causes Fatigue By |
|---|---|---|
| Mitochondrial oxidative phosphorylation | Electron transport chain, adenosine triphosphate (ATP) synthase, coenzyme Q10 | Reduced ATP production; seen in mitochondrial myopathies, chronic fatigue syndrome, and aging |
| Glycolysis and glucose utilization | Glucose transporters, glycolytic enzymes, insulin signaling | Impaired cellular fuel availability; seen in diabetes, insulin resistance, and hypoglycemia |
| Oxygen delivery | Hemoglobin, cardiac output, pulmonary gas exchange | Tissue hypoxia; seen in anemia, heart failure, and lung disease |
| Thyroid hormone regulation | Thyroxine (T4), triiodothyronine (T3), thyroid-stimulating hormone (TSH) | Reduced basal metabolic rate; seen in hypothyroidism |
How Conditions Cause Fatigue
| Condition | Primary Mechanism | Treatment Implication |
|---|---|---|
| Depression | Monoamine depletion (serotonin, norepinephrine, dopamine); hypothalamic-pituitary-adrenal axis dysregulation; neuroinflammation | Antidepressants targeting monoamines; consider activating agents (bupropion) for prominent fatigue |
| Anemia | Reduced oxygen-carrying capacity leading to tissue hypoxia and compensatory tachycardia | Identify and treat underlying cause; iron supplementation if iron deficiency; transfusion if severe |
| Hypothyroidism | Decreased basal metabolic rate; reduced protein synthesis; impaired neurotransmitter function | Levothyroxine replacement; monitor TSH for dose titration |
| Obstructive sleep apnea | Sleep fragmentation; intermittent hypoxia; sympathetic activation; disrupted sleep architecture | Continuous positive airway pressure (CPAP); weight loss; positional therapy |
| Heart failure | Reduced cardiac output; skeletal muscle underperfusion; neurohormonal activation; deconditioning | Guideline-directed medical therapy; cardiac rehabilitation; diuretics for congestion |
| Diabetes mellitus | Impaired glucose utilization; osmotic symptoms; microvascular complications; autonomic dysfunction | Glycemic control; screen for complications; assess sleep and mood |
| Myalgic encephalomyelitis/chronic fatigue syndrome | Immune dysregulation; mitochondrial dysfunction; autonomic dysfunction; neuroinflammation | Activity pacing; treat comorbid conditions; avoid overexertion (graded exercise controversial) |
| Chronic infections (hepatitis C, HIV, tuberculosis) | Chronic immune activation; cytokine release; direct tissue damage; treatment side effects | Treat underlying infection; assess for anemia and endocrine dysfunction |
| Malignancy | Cytokine-mediated (interleukin-6, tumor necrosis factor); anemia; metabolic derangements; cachexia | Treat underlying malignancy; exercise programs; address anemia and nutrition |
| Autoimmune disease (lupus, rheumatoid arthritis) | Chronic inflammation; cytokine effects on brain; anemia of chronic disease; medication effects | Disease-modifying therapy; address sleep and mood; treat anemia |
Inflammatory and Immune Mechanisms
Cytokine-Induced Fatigue: Pro-inflammatory cytokines (interleukin-1, interleukin-6, tumor necrosis factor-alpha, interferons) induce “sickness behavior” — a constellation of fatigue, malaise, anorexia, and social withdrawal that is evolutionarily conserved to promote rest during infection.
| Cytokine | Source | Effect on Fatigue |
|---|---|---|
| Interleukin-1 beta | Macrophages, microglia | Induces sleep, reduces motivation, activates hypothalamic-pituitary-adrenal axis |
| Interleukin-6 | Multiple cell types; elevated in chronic disease | Correlates with fatigue severity; mediates acute phase response |
| Tumor necrosis factor-alpha | Macrophages, adipocytes | Reduces muscle protein synthesis; impairs insulin signaling; induces anorexia |
| Interferons (alpha, gamma) | Immune cells; used therapeutically | Potent fatigue inducers; seen with interferon therapy and viral infections |
Hypothalamic-Pituitary-Adrenal Axis Dysregulation
Normal Function
- Corticotropin-releasing hormone from hypothalamus
- Adrenocorticotropic hormone from pituitary
- Cortisol release from adrenal glands
- Negative feedback maintains homeostasis
- Diurnal variation (peak in morning)
Dysregulation Patterns
- Blunted cortisol awakening response: Associated with chronic fatigue syndrome and burnout
- Flattened diurnal curve: Seen in depression, chronic stress, and cancer-related fatigue
- Adrenal insufficiency: Causes profound fatigue with orthostatic hypotension
- Chronic stress: Initial hyperactivation followed by hypoactivity
Often Overlooked Mechanism: Post-Exertional Malaise
In myalgic encephalomyelitis/chronic fatigue syndrome, post-exertional malaise represents a pathological response to activity where symptoms worsen 24 to 72 hours after physical or cognitive exertion — distinct from normal exercise-induced fatigue that improves with rest. This reflects abnormal metabolic and immune responses to exertion. Recognizing this pattern is crucial because graded exercise therapy, helpful in deconditioning, may worsen symptoms in patients with true myalgic encephalomyelitis/chronic fatigue syndrome. Always ask: “Do you feel worse a day or two after activity?”
Medication-Induced Fatigue: Mechanisms
| Drug Class | Mechanism of Fatigue | Examples |
|---|---|---|
| Beta-blockers | Reduced cardiac output; central nervous system effects; blunted exercise response | Metoprolol, atenolol, propranolol |
| Antihistamines | Central histamine receptor blockade (H1); anticholinergic effects | Diphenhydramine, hydroxyzine, first-generation agents |
| Benzodiazepines | GABA-A receptor potentiation; central nervous system depression | Diazepam, lorazepam, clonazepam |
| Opioids | Mu-receptor activation; central sedation; hypogonadism with chronic use | Morphine, oxycodone, hydrocodone |
| Antidepressants | Variable — sedating antihistaminic effects versus activating noradrenergic effects | Mirtazapine, trazodone (sedating); bupropion (activating) |
| Antiepileptics | GABA potentiation; sodium channel blockade; central nervous system depression | Gabapentin, pregabalin, valproate, topiramate |
Sleep and Circadian Rhythm Disruption
Sleep Deprivation Effects
Acute: Impaired attention, reaction time, and decision-making; microsleeps
Chronic: Metabolic dysregulation (insulin resistance); immune suppression; increased inflammatory markers; cognitive impairment
Key point: Even modest sleep restriction (6 hours versus 8 hours) accumulates sleep debt and impairs daytime function
Circadian Misalignment
Causes: Shift work, jet lag, irregular schedules, delayed sleep phase disorder
Effects: Hormonal desynchronization; impaired melatonin secretion; misaligned cortisol rhythm; metabolic dysfunction
Key point: Social jet lag (weekend versus weekday sleep timing differences) affects up to 70% of the population
3. History Taking
A comprehensive approach to eliciting the fatigue history
Red Flags — Require Urgent Evaluation
- Unintentional weight loss greater than 5% — Suggests malignancy, hyperthyroidism, chronic infection, or advanced chronic disease
- Fever or night sweats — Suggests infection, malignancy (lymphoma), or autoimmune disease
- Lymphadenopathy — Suggests malignancy or infection
- New or progressive neurological symptoms — Suggests multiple sclerosis, myasthenia gravis, or intracranial pathology
- Severe or rapidly progressive weakness — Suggests neuromuscular emergency or malignancy
- Shortness of breath at rest or orthopnea — Suggests heart failure, severe anemia, or pulmonary disease
- Chest pain or palpitations — Suggests cardiac disease requiring evaluation
- Suicidal ideation — Requires immediate psychiatric assessment
- Age greater than 50 with new-onset fatigue — Higher risk of malignancy; lower threshold for investigation
- Signs of bleeding (melena, hematuria, menorrhagia) — Suggests anemia requiring urgent evaluation
Systematic History: The “TIRED” Approach
Use the mnemonic “TIRED” to ensure comprehensive history taking for fatigue:
- T — Timeline and Triggers: When did it start? Sudden or gradual? What makes it better or worse? Is it constant or fluctuating? Any identifiable precipitants (illness, stress, medication change)?
- I — Impact and Intensity: How severe is it on a scale of 1 to 10? How does it affect work, relationships, and daily activities? Can you exercise? What can you no longer do that you used to?
- R — Rest and Recovery: Does sleep help? How many hours do you sleep? Do you wake refreshed? Do you have difficulty falling or staying asleep? Do you snore or stop breathing at night? Do you feel worse after exertion?
- E — Emotional and Energy: How is your mood? Do you feel sad, anxious, or hopeless? Have you lost interest in things you used to enjoy? Do you have mental fog or difficulty concentrating? Is the fatigue more physical or mental?
- D — Diet, Drugs, and Disease: How is your appetite? Have you lost or gained weight? What medications are you taking (including over-the-counter and supplements)? Do you have any chronic medical conditions? Any recent infections?
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Depression | Low mood, anhedonia, sleep disturbance, appetite changes, guilt, concentration difficulties | “Over the past two weeks, have you felt down, depressed, or hopeless? Have you lost interest or pleasure in doing things?” |
| Anxiety disorders | Excessive worry, restlessness, muscle tension, sleep disturbance, irritability | “Do you find yourself worrying excessively about things? Do you feel on edge or have trouble relaxing?” |
| Obstructive sleep apnea | Snoring, witnessed apneas, morning headaches, nocturia, obesity, large neck circumference | “Has anyone told you that you snore loudly or stop breathing during sleep? Do you wake up with headaches?” |
| Insomnia | Difficulty initiating or maintaining sleep, early morning awakening, daytime impairment | “How long does it take you to fall asleep? Do you wake up during the night? Do you wake earlier than you would like?” |
| Hypothyroidism | Cold intolerance, weight gain, constipation, dry skin, hair loss, menstrual irregularities | “Have you noticed increased sensitivity to cold? Have you gained weight despite not eating more? Is your skin dry or is your hair falling out?” |
| Anemia | Pallor, dyspnea on exertion, palpitations, lightheadedness, pica (iron deficiency) | “Do you get short of breath with activities that didn’t bother you before? Have you noticed looking pale? Are your periods heavy?” |
| Diabetes mellitus | Polyuria, polydipsia, weight change, blurred vision, recurrent infections | “Are you urinating more frequently than usual? Are you excessively thirsty? Have you had recurrent infections?” |
| Heart failure | Dyspnea on exertion, orthopnea, paroxysmal nocturnal dyspnea, peripheral edema | “Do you get short of breath lying flat? Do you need extra pillows to sleep? Are your ankles swollen by the end of the day?” |
| Myalgic encephalomyelitis/chronic fatigue syndrome | Post-exertional malaise (hallmark), unrefreshing sleep, cognitive impairment, orthostatic intolerance | “After physical or mental activity, do you feel significantly worse a day or two later? Does rest fully restore your energy?” |
| Adrenal insufficiency | Hypotension, salt craving, hyperpigmentation (primary), nausea, weight loss | “Do you feel dizzy when you stand up quickly? Do you crave salty foods? Have you noticed your skin getting darker?” |
| Malignancy | Weight loss, night sweats, pain, lymphadenopathy, change in bowel habits | “Have you lost weight without trying? Do you wake up drenched in sweat at night? Have you noticed any lumps or bumps?” |
| Chronic infection (hepatitis, HIV, tuberculosis) | Risk factors (travel, exposures, sexual history), fever, weight loss, lymphadenopathy | “Have you traveled recently? Have you had any new sexual partners? Have you been exposed to anyone with tuberculosis?” |
Detailed Sleep History
Essential Sleep Questions
Sleep disorders are a leading cause of fatigue. Every fatigue evaluation should include a thorough sleep history:
- Sleep duration: What time do you go to bed and wake up? (weekdays versus weekends)
- Sleep quality: Do you wake feeling refreshed?
- Sleep latency: How long to fall asleep? (greater than 30 minutes suggests insomnia)
- Sleep continuity: How often do you wake? For how long?
- Snoring and apneas: Do you snore? Has anyone witnessed you stop breathing?
- Restless legs: Do you have uncomfortable sensations in your legs at night that are relieved by movement?
- Sleep environment: Is the bedroom dark, quiet, and cool? Screen use before bed?
- Daytime sleepiness: Do you fall asleep unintentionally during the day? (Epworth Sleepiness Scale)
Medication and Substance History
Medications That Commonly Cause Fatigue
- Beta-blockers — Metoprolol, atenolol, propranolol (especially lipophilic agents)
- Antihistamines — Diphenhydramine, hydroxyzine, first-generation agents
- Benzodiazepines and sedative-hypnotics — Diazepam, lorazepam, zolpidem
- Opioids — All agents; chronic use causes hypogonadism
- Antidepressants — Mirtazapine, trazodone, tricyclics (sedating); selective serotonin reuptake inhibitors can cause either fatigue or activation
- Antiepileptics — Gabapentin, pregabalin, valproate, topiramate
- Antipsychotics — Quetiapine, olanzapine (highly sedating)
- Muscle relaxants — Cyclobenzaprine, baclofen, tizanidine
- Antihypertensives — Clonidine, methyldopa, reserpine
- Chemotherapy agents — Nearly universal fatigue during treatment
- Interferons — Used for hepatitis and multiple sclerosis
Substance Use and Lifestyle Factors
- Alcohol: Disrupts sleep architecture even in moderate amounts; ask about quantity and timing
- Caffeine: Excessive use causes dependence; withdrawal causes fatigue; late-day use disrupts sleep
- Cannabis: Chronic use associated with amotivation and sleep disruption
- Stimulants: Withdrawal causes profound fatigue; chronic use depletes catecholamines
- Tobacco: Associated with sleep disturbance; nicotine withdrawal during sleep
- Physical activity: Sedentary lifestyle worsens fatigue; ask about exercise habits
- Diet: Irregular eating, skipped meals, very low-calorie diets, and nutritional deficiencies
- Screen time: Blue light exposure before bed disrupts melatonin secretion
Social and Occupational History
| Domain | Key Questions | Why It Matters |
|---|---|---|
| Work | What do you do for work? How many hours per week? Night shifts? Job stress or satisfaction? | Shift work disrupts circadian rhythms; burnout is common cause of fatigue; occupational exposures |
| Relationships | How are things at home? Relationship stress? Caregiving responsibilities? | Caregiver burden is exhausting; relationship conflict affects sleep and mood |
| Finances | Are you experiencing financial stress? | Financial worry is a major cause of anxiety and sleep disturbance |
| Recent life events | Have there been any major changes or losses recently? Bereavement? | Grief and adjustment disorders commonly present with fatigue |
| Exercise and activity | What physical activity do you do? Has this changed recently? | Physical deconditioning perpetuates fatigue; sudden reduction may indicate illness |
| Exposures | Any exposures to chemicals, dust, or fumes at work or home? Recent renovations? | Carbon monoxide, lead, and organic solvents can cause fatigue |
Useful Screening Tools
Depression and Anxiety
PHQ-9: 9-item Patient Health Questionnaire for depression screening; score of 10 or greater suggests moderate depression
PHQ-2: Two screening questions (mood and anhedonia); positive if either endorsed
GAD-7: 7-item Generalized Anxiety Disorder scale; score of 10 or greater suggests moderate anxiety
Sleep Disorders
Epworth Sleepiness Scale: 8-item questionnaire; score greater than 10 suggests excessive daytime sleepiness
STOP-BANG: Screening for obstructive sleep apnea (Snoring, Tired, Observed apneas, Pressure, BMI, Age, Neck, Gender); score of 3 or greater is high risk
Insomnia Severity Index: 7-item questionnaire; score greater than 14 suggests clinical insomnia
4. Physical Examination
A systematic head-to-toe approach for fatigue
Systematic Framework: Use the “Head to Extremities” approach for complete examination of patients presenting with fatigue. The physical examination in fatigue serves two purposes: identifying clues to specific diagnoses and ruling out serious underlying conditions.
General Inspection
- Appearance: Does the patient look unwell? Assess grooming and self-care (may be poor in depression)
- Body habitus: Obesity (sleep apnea risk), cachexia (malignancy, chronic disease), muscle wasting
- Affect and demeanor: Flat affect, psychomotor retardation, or agitation (psychiatric illness)
- Skin color: Pallor (anemia), jaundice (liver disease), hyperpigmentation (Addison disease), gray (hemochromatosis)
- Respiratory pattern: Tachypnea, use of accessory muscles (cardiopulmonary disease)
- Level of alertness: Drowsiness versus true fatigue; ability to stay awake during consultation
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Temperature | Fever (greater than 38°C) or hypothermia | Fever suggests infection or malignancy; hypothermia may indicate hypothyroidism or sepsis |
| Heart Rate | Tachycardia (greater than 100 bpm) or bradycardia (less than 60 bpm) | Tachycardia suggests anemia, hyperthyroidism, heart failure, or anxiety; bradycardia suggests hypothyroidism or heart block |
| Blood Pressure | Hypotension (systolic less than 90 mmHg) or hypertension; orthostatic changes | Hypotension suggests adrenal insufficiency, dehydration, or autonomic dysfunction; always check orthostatics |
| Respiratory Rate | Tachypnea (greater than 20 breaths per minute) | Suggests anemia, heart failure, pulmonary disease, or metabolic acidosis |
| Oxygen Saturation | Hypoxemia (less than 94% on room air) | Suggests pulmonary disease, heart failure, or severe anemia |
| Weight and Body Mass Index | Recent weight change; obesity or underweight | Weight loss suggests malignancy, hyperthyroidism, diabetes, or chronic disease; obesity increases risk of sleep apnea and diabetes |
Orthostatic Vital Signs
Always check in fatigue patients. Measure blood pressure and heart rate after lying supine for 5 minutes, then immediately upon standing and after 3 minutes standing.
- Positive orthostatic hypotension: Systolic drop of 20 mmHg or greater, diastolic drop of 10 mmHg or greater, or heart rate increase of 30 bpm or greater
- Suggests: Dehydration, adrenal insufficiency, autonomic dysfunction, medications (diuretics, antihypertensives), or postural orthostatic tachycardia syndrome
Head and Neck Examination
Head and Face
- Hair: Thinning, coarse texture, or loss of outer eyebrows (hypothyroidism); patchy loss (autoimmune)
- Face: Moon facies (Cushing syndrome); puffy face (hypothyroidism, nephrotic syndrome)
- Eyes: Pallor of conjunctivae (anemia); scleral icterus (liver disease); lid lag or proptosis (hyperthyroidism)
- Mouth: Glossitis or angular cheilitis (iron or B12 deficiency); oral candidiasis (diabetes, immunosuppression)
Neck
- Thyroid: Enlargement, nodules, or tenderness (thyroid disease)
- Lymph nodes: Cervical lymphadenopathy (infection, malignancy)
- Jugular venous pressure: Elevation (heart failure, pericardial disease)
- Neck circumference: Greater than 43 cm in men or 41 cm in women increases sleep apnea risk
Cardiovascular Examination
Inspection and Palpation
- Peripheral edema: Pitting edema of ankles and legs (heart failure, venous insufficiency, hypoalbuminemia)
- Apex beat: Displaced apex (cardiomegaly); heaves or thrills
- Capillary refill: Delayed greater than 2 seconds (poor perfusion)
Auscultation
| Finding | Description | Conditions |
|---|---|---|
| Third heart sound (S3) | Low-pitched sound in early diastole; “gallop” rhythm | Heart failure with volume overload |
| Fourth heart sound (S4) | Low-pitched sound in late diastole | Diastolic dysfunction, hypertensive heart disease |
| Murmurs | Systolic or diastolic; note location, radiation, and grade | Valvular heart disease; flow murmur in severe anemia |
| Irregular rhythm | Irregularly irregular pulse | Atrial fibrillation (associated with fatigue and may indicate thyroid disease) |
Respiratory Examination
Inspection
- Respiratory effort: Use of accessory muscles, pursed lip breathing, tripod positioning
- Chest shape: Barrel chest (chronic obstructive pulmonary disease), kyphoscoliosis
Auscultation
| Finding | Description | Conditions |
|---|---|---|
| Crackles (rales) | Fine or coarse inspiratory sounds | Pulmonary edema (heart failure), interstitial lung disease, pneumonia |
| Wheezes | High-pitched musical sounds, usually expiratory | Asthma, chronic obstructive pulmonary disease, heart failure (“cardiac asthma”) |
| Decreased breath sounds | Reduced air entry to lung bases | Pleural effusion, consolidation, chronic obstructive pulmonary disease |
Abdominal Examination
- Hepatomegaly: Enlarged liver (heart failure, malignancy, fatty liver disease, hepatitis)
- Splenomegaly: Enlarged spleen (hematologic malignancy, chronic infection, portal hypertension)
- Ascites: Shifting dullness, fluid wave (liver disease, malignancy, heart failure)
- Masses: Abdominal or pelvic masses (malignancy)
- Tenderness: Right upper quadrant (liver disease); epigastric (peptic ulcer, pancreatitis)
Skin Examination
| Finding | Description | Suggests |
|---|---|---|
| Pallor | Pale skin, palmar creases, conjunctivae, nail beds | Anemia |
| Jaundice | Yellow discoloration of skin and sclerae | Liver disease, hemolysis |
| Hyperpigmentation | Diffuse darkening, especially skin creases, buccal mucosa, scars | Primary adrenal insufficiency (Addison disease) |
| Dry, coarse skin | Rough texture, scaling | Hypothyroidism |
| Warm, moist skin | Fine texture, diaphoresis | Hyperthyroidism |
| Rashes | Malar rash, discoid lesions, photosensitivity | Systemic lupus erythematosus |
| Petechiae or bruising | Small red spots or ecchymoses | Thrombocytopenia, bleeding disorder, liver disease |
Neurological Examination
Motor Examination
- Muscle bulk: Wasting (myopathy, neuropathy, disuse)
- Tone: Increased (upper motor neuron); decreased (lower motor neuron)
- Power: Proximal weakness (myopathy); distal weakness (neuropathy); fatigable weakness (myasthenia gravis)
- Reflexes: Delayed relaxation (hypothyroidism); hyporeflexia (neuropathy)
Other Neurological Signs
- Sensory examination: Peripheral neuropathy pattern (stocking-glove)
- Coordination: Cerebellar signs (multiple sclerosis)
- Cognitive assessment: Concentration, memory (depression, early dementia)
- Ptosis: Unilateral or bilateral; worsens with fatigue (myasthenia gravis)
Musculoskeletal Examination
- Joint swelling or tenderness: Inflammatory arthritis (rheumatoid arthritis, lupus)
- Tender points: Multiple tender points (fibromyalgia — 11 of 18 sites historically used)
- Range of motion: Limited by pain or stiffness (inflammatory arthritis, fibromyalgia)
Lymph Node Examination
- Cervical: Anterior and posterior chains
- Axillary: Central, lateral, pectoral, subscapular groups
- Inguinal: Horizontal and vertical groups
- Significance: Generalized lymphadenopathy suggests lymphoma, chronic infection (HIV, tuberculosis), or autoimmune disease
Expected Findings by Etiology
| Condition | General Appearance | Key Examination Findings | Other Clues |
|---|---|---|---|
| Depression | Poor grooming, flat affect, psychomotor changes | Usually normal physical examination | Tearfulness, poor eye contact, slow responses |
| Hypothyroidism | Puffy face, weight gain, slow movements | Goiter, bradycardia, dry skin, delayed reflexes | Coarse hair, periorbital edema, hoarse voice |
| Anemia | Pallor, tachycardia | Pale conjunctivae and palmar creases, flow murmur | Koilonychia (iron deficiency), glossitis (B12) |
| Heart failure | Dyspneic, sitting upright | Elevated jugular venous pressure, S3 gallop, edema, crackles | Displaced apex, hepatomegaly |
| Obstructive sleep apnea | Obese, large neck | Crowded oropharynx, large tongue, narrow airway | Mallampati class III or IV |
| Adrenal insufficiency | Thin, hypotensive | Hyperpigmentation, orthostatic hypotension | Darkening of scars, gum pigmentation |
| Malignancy | Cachexia, weight loss | Lymphadenopathy, hepatosplenomegaly, masses | Varies by cancer type |
| Myalgic encephalomyelitis/chronic fatigue syndrome | May appear well | Usually normal physical examination | Diagnosis of exclusion; positive orthostatic test common |
Important Teaching Point
Normal examination is common! Many causes of fatigue — including depression, anxiety, early thyroid disease, mild anemia, sleep disorders, medication side effects, and myalgic encephalomyelitis/chronic fatigue syndrome — present with entirely normal or near-normal physical examination findings. A normal examination does not exclude significant pathology. The history remains the most important diagnostic tool in evaluating fatigue, and laboratory investigation is often required to identify the underlying cause.
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
Acute Fatigue (Duration: Less than 1 month)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 70%) | Viral infection (upper respiratory infection, influenza, mononucleosis) | Preceding or concurrent respiratory or gastrointestinal symptoms, fever, myalgias, recent sick contacts | Persistent fever greater than 2 weeks, severe lymphadenopathy |
| COMMON | Acute stress or adjustment disorder | Identifiable stressor (job loss, relationship problems, bereavement), anxiety, sleep disturbance | Suicidal ideation, inability to function |
| COMMON | Sleep deprivation | Recent change in sleep schedule, new baby, shift work, travel across time zones | None specific |
| COMMON | Medication side effect or new medication | Temporal relationship to starting or increasing medication dose | Symptoms suggestive of drug toxicity |
| LESS COMMON (approximately 20%) | Early pregnancy | Reproductive age female, missed period, nausea, breast tenderness | Vaginal bleeding, severe abdominal pain |
| LESS COMMON | Anemia (acute blood loss) | Pallor, tachycardia, history of bleeding (gastrointestinal, menstrual) | Hemodynamic instability, melena, hematemesis |
| UNCOMMON BUT SERIOUS (approximately 10%) | Acute cardiac event (heart failure, arrhythmia) | Dyspnea, chest discomfort, palpitations, peripheral edema, orthopnea | Severe dyspnea, syncope, chest pain |
| UNCOMMON BUT SERIOUS | Carbon monoxide poisoning | Headache, multiple household members affected, winter months, faulty heating | Confusion, loss of consciousness |
| UNCOMMON BUT SERIOUS | Adrenal crisis | Hypotension, nausea, abdominal pain, history of steroid use or adrenal disease | Shock, altered mental status |
Subacute Fatigue (Duration: 1 to 6 months)
| Probability | Condition | Key Features | Expected Course |
|---|---|---|---|
| COMMON (approximately 60%) | Depression | Low mood, anhedonia, sleep and appetite changes, guilt, concentration problems | May persist or worsen without treatment; responds to antidepressants and therapy |
| COMMON | Post-viral fatigue syndrome | Follows documented viral illness, gradual improvement expected | Usually resolves within 3 to 6 months; if persists beyond 6 months, consider myalgic encephalomyelitis/chronic fatigue syndrome |
| COMMON | Anemia (iron deficiency, vitamin B12 deficiency) | Pallor, dyspnea on exertion, pica, glossitis, paresthesias (B12) | Improves with replacement therapy over weeks to months |
| COMMON | Thyroid dysfunction (hypothyroidism or hyperthyroidism) | Weight changes, temperature intolerance, skin and hair changes, menstrual irregularities | Improves with treatment over weeks to months |
| LESS COMMON (approximately 25%) | Diabetes mellitus (new or poorly controlled) | Polyuria, polydipsia, weight loss, blurred vision, recurrent infections | Improves with glycemic control |
| LESS COMMON | Sleep disorder (obstructive sleep apnea, insomnia) | Snoring, witnessed apneas, unrefreshing sleep, daytime sleepiness | Improves with continuous positive airway pressure or insomnia treatment |
| LESS COMMON | Chronic infection (hepatitis B or C, HIV, tuberculosis) | Risk factors, fever, night sweats, weight loss, lymphadenopathy | Depends on treatment of underlying infection |
| UNCOMMON BUT SERIOUS (approximately 15%) | Malignancy | Weight loss, night sweats, lymphadenopathy, new masses, change in bowel habits | Depends on cancer type and stage |
| UNCOMMON BUT SERIOUS | Heart failure | Dyspnea on exertion, orthopnea, paroxysmal nocturnal dyspnea, peripheral edema | Progressive without treatment; improves with guideline-directed therapy |
| UNCOMMON BUT SERIOUS | Autoimmune disease (systemic lupus erythematosus, rheumatoid arthritis) | Joint pain, rashes, photosensitivity, oral ulcers, serositis | Chronic relapsing course; improves with immunosuppressive therapy |
Chronic Fatigue (Duration: Greater than 6 months)
Step-by-Step Approach to Chronic Fatigue:
- Step 1: Rule out obvious causes — Is the patient taking a fatigue-causing medication? Is there a clear psychiatric component (depression, anxiety)? Is there obvious sleep deprivation or a sleep disorder?
- Step 2: Screen for the “Big Five” — Depression/anxiety, sleep disorders, lifestyle factors (sedentary, obesity), medications, and common medical conditions (anemia, thyroid disease, diabetes)
- Step 3: Consider less common but serious causes — Malignancy, heart failure, chronic infection, autoimmune disease, adrenal insufficiency
- Step 4: If workup negative and criteria met — Consider myalgic encephalomyelitis/chronic fatigue syndrome or fibromyalgia
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Depression and anxiety disorders | 30 to 40% | Low mood, anhedonia, excessive worry, sleep disturbance, appetite changes; responds to psychiatric treatment |
| COMMON | Sleep disorders (obstructive sleep apnea, chronic insomnia) | 15 to 25% | Unrefreshing sleep, daytime sleepiness, snoring, obesity, large neck; polysomnography diagnostic |
| COMMON | Lifestyle factors (sedentary, obesity, poor sleep hygiene) | 10 to 20% | Physical inactivity, irregular sleep schedule, excessive screen time, poor diet; improves with lifestyle modification |
| COMMON | Medication-induced fatigue | 5 to 10% | Temporal relationship to medication; common culprits include beta-blockers, antihistamines, benzodiazepines, antiepileptics |
| LESS COMMON | Anemia | 5 to 10% | Pallor, dyspnea on exertion; hemoglobin less than 12 g/dL in women, less than 13 g/dL in men |
| LESS COMMON | Hypothyroidism | 3 to 5% | Cold intolerance, weight gain, constipation, dry skin; elevated thyroid-stimulating hormone |
| LESS COMMON | Diabetes mellitus | 2 to 5% | Polyuria, polydipsia, neuropathy; elevated fasting glucose or hemoglobin A1c |
| LESS COMMON | Myalgic encephalomyelitis/chronic fatigue syndrome | 1 to 3% | Post-exertional malaise (hallmark), unrefreshing sleep, cognitive impairment; diagnosis of exclusion |
| LESS COMMON | Fibromyalgia | 2 to 4% | Widespread pain, multiple tender points, sleep disturbance, cognitive symptoms |
| UNCOMMON BUT SERIOUS | Malignancy | 1 to 3% | Weight loss, night sweats, lymphadenopathy; higher suspicion in patients over age 50 |
| UNCOMMON BUT SERIOUS | Heart failure | 1 to 2% | Dyspnea, orthopnea, peripheral edema, elevated jugular venous pressure, S3 gallop |
| UNCOMMON BUT SERIOUS | Chronic kidney disease | 1 to 2% | Nausea, pruritus, edema, hypertension; elevated creatinine, decreased glomerular filtration rate |
| UNCOMMON BUT SERIOUS | Chronic liver disease | Less than 1% | Jaundice, ascites, spider angiomata, hepatomegaly; abnormal liver function tests |
| UNCOMMON BUT SERIOUS | Adrenal insufficiency | Less than 1% | Hypotension, hyperpigmentation, salt craving, weight loss; low morning cortisol |
| UNCOMMON BUT SERIOUS | Multiple sclerosis | Less than 1% | Young adults, episodic neurological symptoms, heat sensitivity; MRI and lumbar puncture diagnostic |
Categorical Approach to Fatigue
Psychiatric and Psychological
Major depressive disorder
Generalized anxiety disorder
Somatization disorder
Burnout syndrome
Adjustment disorder
Bipolar disorder (depressive phase)
Sleep-Related
Obstructive sleep apnea
Chronic insomnia
Restless legs syndrome
Circadian rhythm disorders
Narcolepsy
Periodic limb movement disorder
Endocrine and Metabolic
Hypothyroidism
Hyperthyroidism
Diabetes mellitus
Adrenal insufficiency
Hypercalcemia
Hypogonadism
Organ System Disease
Heart failure
Chronic kidney disease
Chronic liver disease
Chronic obstructive pulmonary disease
Anemia (all causes)
Malignancy
Infectious
Hepatitis B and C
HIV infection
Tuberculosis
Infectious mononucleosis
Lyme disease
Endocarditis
Inflammatory and Autoimmune
Systemic lupus erythematosus
Rheumatoid arthritis
Sjögren syndrome
Inflammatory bowel disease
Polymyalgia rheumatica
Sarcoidosis
Neurological
Multiple sclerosis
Parkinson disease
Myasthenia gravis
Myopathies
Peripheral neuropathy
Post-concussion syndrome
Functional and Other
Myalgic encephalomyelitis/chronic fatigue syndrome
Fibromyalgia
Long COVID syndrome
Medication-induced
Nutritional deficiencies
Deconditioning
Drug-Induced Fatigue
| Drug or Drug Class | Mechanism | Characteristics | Time to Resolution After Stopping |
|---|---|---|---|
| Beta-blockers | Reduced cardiac output, central nervous system effects, blunted exercise response | Fatigue, exercise intolerance, bradycardia; worse with lipophilic agents (propranolol, metoprolol) | Days to 2 weeks |
| First-generation antihistamines | Central histamine H1 receptor blockade, anticholinergic effects | Sedation, cognitive impairment, dry mouth; diphenhydramine is common culprit | 24 to 48 hours |
| Benzodiazepines | GABA-A receptor potentiation, central nervous system depression | Sedation, cognitive impairment, next-day hangover; long-acting agents worse | Days to weeks (depends on half-life) |
| Opioids | Mu-receptor activation, central sedation, hypogonadism with chronic use | Sedation, constipation; chronic use causes testosterone deficiency | Days; hypogonadism may persist |
| Antidepressants (sedating) | Antihistaminic and anticholinergic effects (mirtazapine, trazodone, tricyclics) | Sedation, weight gain; often improves with continued use | Days to 1 week |
| Antiepileptics | GABA potentiation, sodium channel blockade | Sedation, cognitive slowing; gabapentin, pregabalin, valproate, topiramate | Days to 1 week |
| Antipsychotics | Dopamine blockade, antihistaminic effects | Sedation, metabolic syndrome; quetiapine and olanzapine highly sedating | Days to 1 week |
| Muscle relaxants | Central nervous system depression | Sedation, dizziness; cyclobenzaprine, baclofen, tizanidine | 24 to 72 hours |
| Centrally acting antihypertensives | Alpha-2 agonism (clonidine), dopamine depletion (reserpine) | Sedation, depression, bradycardia | Days to 1 week |
| Proton pump inhibitors | Possible magnesium and B12 malabsorption with chronic use | Usually mild; consider with long-term use | Weeks to months (if due to deficiency) |
| Statins | Mitochondrial effects, possible coenzyme Q10 depletion | Fatigue and myalgias; may be dose-related | Weeks |
| Interferons | Cytokine-mediated sickness behavior | Prominent fatigue, flu-like symptoms, depression | Weeks to months after discontinuation |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Fatigue + low mood + anhedonia + sleep disturbance | Depression | PHQ-9 screening; psychiatric evaluation |
| Fatigue + snoring + obesity + daytime sleepiness | Obstructive sleep apnea | STOP-BANG questionnaire; polysomnography |
| Fatigue + cold intolerance + weight gain + constipation | Hypothyroidism | Thyroid-stimulating hormone level |
| Fatigue + pallor + dyspnea on exertion + tachycardia | Anemia | Complete blood count; iron studies |
| Fatigue + polyuria + polydipsia + weight loss | Diabetes mellitus | Fasting glucose; hemoglobin A1c |
| Fatigue + orthopnea + peripheral edema + dyspnea | Heart failure | Brain natriuretic peptide; echocardiogram |
| Fatigue + weight loss + night sweats + lymphadenopathy | Malignancy (especially lymphoma) | Complete blood count; lactate dehydrogenase; CT imaging |
| Fatigue + post-exertional malaise + unrefreshing sleep | Myalgic encephalomyelitis/chronic fatigue syndrome | Exclude other causes; apply diagnostic criteria |
| Fatigue + widespread pain + tender points | Fibromyalgia | Apply American College of Rheumatology criteria |
| Fatigue + hypotension + hyperpigmentation + salt craving | Adrenal insufficiency | Morning cortisol; adrenocorticotropic hormone stimulation test |
| Fatigue + joint pain + malar rash + photosensitivity | Systemic lupus erythematosus | Antinuclear antibody; complete blood count; urinalysis |
| Fatigue + recent medication change | Medication-induced fatigue | Review medication list; consider trial discontinuation |
| Fatigue + proximal weakness + worsening through the day | Myasthenia gravis | Acetylcholine receptor antibodies; electromyography |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
Baseline Investigations for All Patients with Unexplained Fatigue
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Complete blood count | Screen for anemia, infection, hematologic malignancy | Low hemoglobin (anemia); elevated or low white blood cell count; abnormal platelets | Hemoglobin less than 12 g/dL (women) or less than 13 g/dL (men) indicates anemia; check mean corpuscular volume for type |
| Comprehensive metabolic panel | Screen for kidney disease, liver disease, electrolyte abnormalities, glucose | Elevated creatinine; elevated liver enzymes; abnormal glucose; electrolyte imbalances | Fasting glucose greater than 126 mg/dL suggests diabetes; random glucose greater than 200 mg/dL with symptoms is diagnostic |
| Thyroid-stimulating hormone | Screen for thyroid dysfunction | Elevated thyroid-stimulating hormone (hypothyroidism); low thyroid-stimulating hormone (hyperthyroidism) | Most sensitive screening test; if abnormal, check free T4 and free T3 |
| Erythrocyte sedimentation rate and/or C-reactive protein | Screen for inflammation, infection, malignancy | Elevated values suggest inflammatory process | Nonspecific but helpful; very high values (greater than 100 mm/hour) suggest serious underlying disease |
| Urinalysis | Screen for kidney disease, diabetes, infection | Proteinuria; glucosuria; hematuria; pyuria | Simple and inexpensive; may reveal occult kidney disease or diabetes |
Second-Tier Investigations (Based on Clinical Suspicion)
| Investigation | When to Order | What to Look For | Interpretation |
|---|---|---|---|
| Iron studies (ferritin, serum iron, total iron-binding capacity) | Anemia present; or high-risk population (menstruating women, vegetarians) | Low ferritin (less than 30 ng/mL suggests iron deficiency); low serum iron; high total iron-binding capacity | Ferritin less than 15 ng/mL is diagnostic of iron deficiency; 15 to 30 ng/mL is borderline; ferritin may be falsely normal if inflammation present |
| Vitamin B12 and folate | Macrocytic anemia; neurological symptoms; elderly; vegetarian/vegan diet | Low B12 (less than 200 pg/mL); low folate | B12 deficiency can cause fatigue even without anemia; check methylmalonic acid if B12 borderline (200 to 400 pg/mL) |
| Vitamin D level (25-hydroxyvitamin D) | Risk factors for deficiency; bone pain; muscle weakness | Less than 20 ng/mL indicates deficiency; 20 to 30 ng/mL indicates insufficiency | Deficiency is common and may contribute to fatigue; supplementation is low risk |
| Hemoglobin A1c | Suspected diabetes; elevated fasting glucose; risk factors | Greater than or equal to 6.5% diagnostic of diabetes; 5.7 to 6.4% indicates prediabetes | More convenient than fasting glucose; reflects average glucose over 3 months |
| Brain natriuretic peptide or N-terminal pro-brain natriuretic peptide | Suspected heart failure; dyspnea; edema | Elevated levels suggest heart failure | Brain natriuretic peptide greater than 100 pg/mL or N-terminal pro-brain natriuretic peptide greater than 300 pg/mL suggests heart failure; lower values essentially rule it out |
| Hepatitis B and C serology | Risk factors (injection drug use, blood transfusion, endemic area); elevated liver enzymes | Hepatitis B surface antigen; hepatitis C antibody | Chronic hepatitis is treatable; important to identify |
| HIV test | Risk factors; unexplained symptoms; routine screening recommended | HIV antigen/antibody test | Fourth-generation tests detect most infections within 2 to 4 weeks; early treatment improves outcomes |
Targeted Investigations by Suspected Etiology
If Suspecting Depression or Anxiety
First-Line Assessment
- PHQ-9: Score of 10 or greater suggests moderate depression
- GAD-7: Score of 10 or greater suggests moderate anxiety
- Clinical interview: Assess for suicidal ideation, substance use, prior episodes
Additional Testing
- Thyroid-stimulating hormone: Rule out thyroid disease mimicking depression
- Complete blood count and comprehensive metabolic panel: Rule out medical causes
- Consider referral: To psychiatry if severe, treatment-resistant, or bipolar suspected
If Suspecting Sleep Disorder
First-Line Assessment
- STOP-BANG questionnaire: Score of 3 or greater indicates high risk for obstructive sleep apnea
- Epworth Sleepiness Scale: Score greater than 10 indicates excessive daytime sleepiness
- Sleep diary: Two-week record of sleep times and quality
Confirmatory Testing
- Polysomnography: Gold standard for obstructive sleep apnea; apnea-hypopnea index of 5 or greater with symptoms is diagnostic
- Home sleep apnea testing: Acceptable alternative in high-probability patients without comorbidities
- Multiple sleep latency test: If narcolepsy suspected
If Suspecting Thyroid Disease
First-Line Tests
- Thyroid-stimulating hormone: Most sensitive screening test
- Free T4: Order if thyroid-stimulating hormone abnormal
Second-Line Tests
- Free T3: If hyperthyroidism suspected with normal T4
- Thyroid peroxidase antibodies: If autoimmune thyroiditis suspected
- Thyroid ultrasound: If nodules palpated
If Suspecting Anemia
First-Line Tests
- Complete blood count with indices: Hemoglobin, mean corpuscular volume, red cell distribution width
- Reticulocyte count: Assess bone marrow response
- Iron studies: Ferritin, serum iron, total iron-binding capacity, transferrin saturation
Second-Line Tests (Based on Results)
- Vitamin B12 and folate: If macrocytic anemia
- Hemoglobin electrophoresis: If hemolysis suspected or appropriate ethnicity
- Peripheral blood smear: If abnormal indices or suspected hematologic disease
- Gastrointestinal evaluation: If iron deficiency in men or postmenopausal women
If Suspecting Adrenal Insufficiency
First-Line Tests
- Morning cortisol (8 AM): Level less than 3 mcg/dL suggests insufficiency; level greater than 15 mcg/dL essentially rules it out
- Basic metabolic panel: Hyponatremia, hyperkalemia (primary adrenal insufficiency)
Confirmatory Testing
- Adrenocorticotropic hormone stimulation test: Gold standard; cortisol should rise to greater than 18 mcg/dL after synthetic adrenocorticotropic hormone administration
- Plasma adrenocorticotropic hormone level: Distinguishes primary (elevated) from secondary (low or normal) adrenal insufficiency
If Suspecting Malignancy
Initial Workup
- Complete blood count: Cytopenias, abnormal white blood cell differential
- Lactate dehydrogenase: Elevated in lymphoma, hemolysis
- Comprehensive metabolic panel: Hypercalcemia, liver function abnormalities
- Erythrocyte sedimentation rate: Often markedly elevated
Imaging and Further Workup
- Chest radiograph: Lung masses, lymphadenopathy
- CT chest, abdomen, and pelvis: If high suspicion or abnormal initial tests
- Age-appropriate cancer screening: Colonoscopy, mammography, prostate-specific antigen as indicated
- Tissue biopsy: If mass or lymphadenopathy identified
Empiric Treatment Trials as Diagnostic Tools
Empiric Therapy Approach
When diagnosis is unclear despite initial workup, empiric treatment trials can serve as both therapeutic and diagnostic tools. Response to therapy supports the diagnosis; lack of response prompts reconsideration.
- Iron supplementation trial: In patients with borderline ferritin (15 to 50 ng/mL), especially menstruating women; trial ferrous sulfate 325 mg daily for 4 to 8 weeks and assess response
- Vitamin D supplementation trial: In patients with levels less than 30 ng/mL; supplement with 2,000 to 4,000 IU daily for 8 to 12 weeks
- Antidepressant trial: If depression suspected but patient ambivalent about diagnosis; select activating agent (bupropion) if fatigue is prominent symptom; reassess at 6 to 8 weeks
- Sleep hygiene intervention: Before polysomnography, trial strict sleep hygiene measures for 2 to 4 weeks; if no improvement and sleep apnea risk factors present, proceed with sleep study
- Medication reduction trial: If medication-induced fatigue suspected, consider tapering or discontinuing suspected agent (with appropriate medical supervision) and reassessing after appropriate washout period
Investigation Pitfalls
Common Mistakes in Fatigue Workup
- Ordering too many tests at once: A stepwise approach is more cost-effective and reduces false positive results
- Accepting “normal” ferritin in young women: Ferritin of 15 to 50 ng/mL may still represent functional iron deficiency
- Missing subclinical hypothyroidism: Thyroid-stimulating hormone of 5 to 10 mIU/L may cause fatigue; consider treatment trial
- Forgetting about medications: Always review medication list before extensive workup
- Not screening for depression: Depression is the most common cause of chronic fatigue; must be actively assessed
- Over-relying on normal test results: Many causes of fatigue (depression, early thyroid disease, myalgic encephalomyelitis/chronic fatigue syndrome) have normal standard laboratory tests
Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Institute of Medicine (2015) Diagnostic Criteria: All three of the following symptoms must be present:
- Substantial reduction in ability to engage in pre-illness levels of activity lasting more than 6 months, accompanied by fatigue that is profound, of new onset (not lifelong), not the result of ongoing exertion, and not substantially relieved by rest
- Post-exertional malaise — worsening of symptoms after physical, mental, or emotional exertion that would not have caused a problem before illness onset
- Unrefreshing sleep
Plus at least ONE of the following:
- Cognitive impairment — problems with thinking, memory, executive function, information processing
- Orthostatic intolerance — worsening of symptoms upon standing, improved with lying down
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Fatigue with suicidal ideation or severe depression | EMERGENT | Immediate psychiatric evaluation; assess safety; consider hospitalization |
| Fatigue with chest pain, severe dyspnea, or syncope | EMERGENT | Emergency department evaluation; ECG; cardiac workup |
| Fatigue with severe anemia (hemoglobin less than 7 g/dL) or active bleeding | EMERGENT | Emergency department; consider transfusion; identify bleeding source |
| Fatigue with hypotension, confusion, or signs of adrenal crisis | EMERGENT | Intravenous fluids; stress-dose corticosteroids; emergency department |
| Fatigue with fever, weight loss, and lymphadenopathy | URGENT | Same-week evaluation; complete blood count, comprehensive metabolic panel, lactate dehydrogenase; imaging within 1 to 2 weeks |
| Fatigue with new neurological symptoms (weakness, numbness, vision changes) | URGENT | Same-week evaluation; neurological examination; consider MRI and neurology referral |
| Fatigue with unintentional weight loss greater than 5% | URGENT | Same-week evaluation; comprehensive workup for malignancy and chronic disease |
| Fatigue with significant functional impairment | URGENT | Evaluation within 1 to 2 weeks; assess for treatable causes; consider work/disability implications |
| Chronic fatigue without red flags, stable symptoms | ROUTINE | Scheduled appointment; systematic workup; lifestyle assessment |
| Fatigue following recent viral illness, improving trajectory | ROUTINE | Reassurance; supportive care; follow-up if not improving by 6 to 8 weeks |
Step 2: Classify by Duration
Acute (Less than 1 month)
Approach: Look for acute precipitants
- Recent illness?
- New medication?
- Life stressor?
- Sleep deprivation?
Proceed to Algorithm A
Subacute (1 to 6 months)
Approach: Systematic workup indicated
- Screen for depression
- Baseline laboratory tests
- Sleep assessment
- Medication review
Proceed to Algorithm B
Chronic (Greater than 6 months)
Approach: Comprehensive evaluation
- Complete workup
- Consider specialist referral
- Assess for myalgic encephalomyelitis/chronic fatigue syndrome
- Multidisciplinary approach
Proceed to Algorithm C
Step 3: Follow the Appropriate Algorithm
Algorithm A: Acute Fatigue (Less than 1 month)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Recent upper respiratory infection or flu-like illness with gradual improvement | Post-infectious fatigue | Reassurance; rest; adequate hydration; follow-up if not improving by 4 to 6 weeks |
| Identifiable life stressor with anxiety and sleep disturbance | Acute stress reaction | Supportive counseling; assess coping; screen for depression; consider short-term sleep aid |
| Recent medication change (within 2 weeks of symptom onset) | Medication-induced fatigue | Review timing; consider dose reduction or alternative agent if appropriate |
| Clear sleep deprivation (new baby, shift work, travel) | Sleep insufficiency | Sleep hygiene education; address barriers to sleep; reassess after sleep normalization |
| Reproductive-age woman with nausea and missed period | Early pregnancy | Pregnancy test; if positive, initiate prenatal care |
| Red flags present (weight loss, fever, bleeding, neurological symptoms) | Serious underlying condition | Urgent workup; do not attribute to benign cause until serious diagnoses excluded |
Algorithm B: Subacute Fatigue (1 to 6 months)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| PHQ-9 score of 10 or greater; low mood; anhedonia; sleep or appetite changes | Major depressive disorder | Discuss treatment options (therapy, medication); consider activating antidepressant (bupropion) if fatigue prominent |
| STOP-BANG score of 3 or greater; snoring; witnessed apneas; excessive daytime sleepiness | Obstructive sleep apnea | Order polysomnography; if confirmed, continuous positive airway pressure therapy; weight loss counseling |
| Elevated thyroid-stimulating hormone; cold intolerance; weight gain; constipation | Hypothyroidism | Start levothyroxine; recheck thyroid-stimulating hormone in 6 to 8 weeks; titrate to normalize |
| Low hemoglobin; pallor; low ferritin or abnormal iron studies | Iron deficiency anemia | Iron replacement; identify and treat underlying cause (gastrointestinal evaluation if male or postmenopausal) |
| Elevated fasting glucose or hemoglobin A1c; polyuria; polydipsia | Diabetes mellitus | Initiate diabetes management; lifestyle modification; medication as indicated |
| Baseline workup normal; follows documented viral illness | Prolonged post-viral fatigue | Reassurance; gradual activity increase; if persists beyond 6 months, evaluate for myalgic encephalomyelitis/chronic fatigue syndrome |
| Red flags present; weight loss; night sweats; lymphadenopathy | Possible malignancy or chronic infection | CT imaging; infectious disease workup (HIV, hepatitis, tuberculosis); consider hematology/oncology referral |
Algorithm C: Chronic Fatigue (Greater than 6 months)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Meets criteria: post-exertional malaise, unrefreshing sleep, cognitive impairment; other causes excluded | Myalgic encephalomyelitis/chronic fatigue syndrome | Educate patient; activity pacing (avoid boom-bust cycle); treat comorbidities; consider specialist referral |
| Widespread pain with tender points; sleep disturbance; no inflammatory markers | Fibromyalgia | Multimodal treatment: low-impact exercise, sleep optimization, duloxetine or pregabalin, cognitive behavioral therapy |
| Treatment-resistant depression; persistent fatigue despite antidepressant | Refractory depression or comorbid condition | Psychiatry referral; consider augmentation strategies; reassess for missed diagnoses (sleep apnea, thyroid) |
| Multiple somatic complaints; extensive negative workup; high healthcare utilization | Somatic symptom disorder | Establish therapeutic alliance; scheduled visits; limit unnecessary testing; cognitive behavioral therapy referral |
| Chronic disease present (heart failure, kidney disease, liver disease, autoimmune) | Fatigue secondary to chronic illness | Optimize underlying disease management; address anemia; screen for depression; exercise rehabilitation |
| Sedentary lifestyle; obesity; poor sleep hygiene; high stress | Lifestyle-related fatigue | Structured lifestyle intervention: graduated exercise program, sleep hygiene, stress management, nutrition counseling |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Initial workup is completely normal | Reassess history for depression, sleep disorder, lifestyle factors; consider subclinical conditions | Second-tier testing (vitamin D, B12, ferritin even if hemoglobin normal); sleep study; psychiatric evaluation |
| Patient is taking a fatigue-causing medication | Discuss with patient; assess risk-benefit of continuing versus changing medication | If appropriate, trial dose reduction or switch to alternative agent; reassess in 2 to 4 weeks |
| Depression screening is positive | Complete PHQ-9; assess suicidal ideation; discuss treatment options | Initiate treatment (antidepressant and/or therapy); follow-up in 2 to 4 weeks; reassess fatigue once mood improves |
| Patient refuses polysomnography despite high sleep apnea risk | Educate about risks of untreated sleep apnea; offer home sleep testing as alternative | If still declines, document discussion; empiric weight loss and positional therapy; reassess periodically |
| Thyroid-stimulating hormone is borderline elevated (5 to 10 mIU/L) | Check thyroid peroxidase antibodies and free T4; assess for hypothyroid symptoms | If symptomatic with positive antibodies, consider levothyroxine trial; if asymptomatic, monitor every 6 to 12 months |
| Ferritin is “normal” but patient has classic iron deficiency symptoms | Recognize that ferritin of 15 to 50 ng/mL may still represent functional deficiency, especially in young women | Trial of iron supplementation for 8 to 12 weeks; reassess symptoms and ferritin |
| Patient insists they have chronic fatigue syndrome but does not meet criteria | Validate their symptoms; explain diagnostic criteria; continue searching for treatable causes | Complete comprehensive workup; address any identified conditions; supportive care regardless of label |
| Fatigue persists despite treating identified cause | Reassess: Was treatment adequate? Is patient compliant? Are there additional/overlapping causes? | Review diagnosis; check for comorbid conditions (depression plus sleep apnea plus thyroid is common); consider specialist referral |
| Patient is over age 50 with new-onset fatigue and no obvious cause | Lower threshold for malignancy workup; ensure age-appropriate cancer screening is current | Consider CT chest/abdomen/pelvis if not improving with initial management; monitor closely |
Troubleshooting Refractory Fatigue
When Fatigue Does Not Improve: Ask These Questions
- Was the treatment duration adequate? Many conditions require 6 to 12 weeks of treatment before fatigue improves (thyroid, depression, anemia)
- Was patient compliance good? Assess adherence to medication, continuous positive airway pressure use, lifestyle changes
- Were all potential causes addressed? Fatigue often has multiple overlapping causes (depression plus sleep apnea plus hypothyroidism)
- Is the diagnosis correct? Consider revisiting the differential; order second-tier tests if not already done
- Are there perpetuating factors? Ongoing stress, poor sleep hygiene, sedentary lifestyle, medications
- Has the patient developed a new condition? Repeat history and examination; consider repeat laboratory tests
- Is this myalgic encephalomyelitis/chronic fatigue syndrome? If criteria met and other causes excluded, shift focus to symptom management
- Would multidisciplinary care help? Consider referrals to psychiatry, sleep medicine, physical therapy, pain management
When to Refer
| Specialist | When to Refer |
|---|---|
| Psychiatry | Treatment-resistant depression; suicidal ideation; bipolar disorder suspected; complex psychiatric comorbidity |
| Sleep Medicine | Suspected sleep apnea requiring polysomnography; complex insomnia; narcolepsy suspected; continuous positive airway pressure intolerance |
| Endocrinology | Complex thyroid disease; suspected adrenal insufficiency; pituitary dysfunction; refractory diabetes |
| Hematology/Oncology | Unexplained cytopenias; suspected malignancy; refractory anemia |
| Rheumatology | Suspected autoimmune disease; positive autoantibodies with symptoms; fibromyalgia not responding to primary care management |
| Neurology | Suspected multiple sclerosis; myasthenia gravis; unexplained neurological symptoms |
| Cardiology | Suspected heart failure; unexplained dyspnea with fatigue; arrhythmia |
| Infectious Disease | Suspected chronic infection; HIV; hepatitis; fever of unknown origin |
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
The Big Five dominate chronic fatigue: Depression, sleep disorders, lifestyle factors, medications, and common medical conditions (anemia, thyroid, diabetes) account for the vast majority of cases. Always screen for these first.
Depression is the most common cause: Up to 40% of chronic fatigue in primary care is due to depression or anxiety. Use PHQ-2 or PHQ-9 screening for every fatigue patient.
Ask about post-exertional malaise: “Do you feel worse a day or two after activity?” A positive answer is the hallmark of myalgic encephalomyelitis/chronic fatigue syndrome and changes management significantly.
Ferritin thresholds are often too low: A “normal” ferritin of 15 to 50 ng/mL may still represent functional iron deficiency, especially in menstruating women. Consider iron supplementation trial even with borderline values.
Review the medication list early: Many common medications cause fatigue (beta-blockers, antihistamines, gabapentinoids, benzodiazepines). A medication change may be the quickest path to improvement.
Normal examination does not exclude serious disease: Depression, early thyroid disease, sleep apnea, and even some malignancies can present with completely normal physical examination findings.
Multiple causes are common: Fatigue often has overlapping etiologies (for example, depression plus sleep apnea plus hypothyroidism). Treating one cause may not resolve symptoms if others remain unaddressed.
Subclinical hypothyroidism can cause fatigue: Thyroid-stimulating hormone of 5 to 10 mIU/L with fatigue and other hypothyroid symptoms may warrant a levothyroxine trial, especially if thyroid peroxidase antibodies are positive.
Critical Pitfalls to Avoid
Dismissing fatigue as “just stress” without evaluation: While stress and lifestyle factors are common causes, fatigue can also be the presenting symptom of serious medical conditions including malignancy, heart failure, and chronic infections. Always perform a systematic evaluation.
Ordering extensive testing before taking a thorough history: The history identifies the likely diagnosis in most cases. Targeted testing based on clinical suspicion is more cost-effective and reduces false positives.
Missing depression because the patient “doesn’t seem depressed”: Many depressed patients present with fatigue as their chief complaint and may not spontaneously report mood symptoms. Always screen with validated tools.
Assuming sleep apnea only affects obese men: Women and non-obese individuals can have obstructive sleep apnea. Clinical features like snoring, witnessed apneas, and excessive daytime sleepiness should prompt evaluation regardless of body habitus.
Recommending graded exercise for all fatigue patients: While exercise helps most fatigue causes, it can worsen symptoms in myalgic encephalomyelitis/chronic fatigue syndrome. Ask about post-exertional malaise before prescribing exercise programs.
Stopping investigation after one normal result: A normal thyroid-stimulating hormone does not exclude all endocrine causes; normal hemoglobin does not exclude iron deficiency. Consider the full differential and second-tier testing when appropriate.
Labeling patients with chronic fatigue syndrome too early: Myalgic encephalomyelitis/chronic fatigue syndrome is a diagnosis of exclusion requiring symptoms for at least 6 months and exclusion of other causes. Premature labeling may result in missed treatable diagnoses.
Ignoring age-related red flags: New-onset fatigue in patients over age 50 warrants a lower threshold for malignancy workup, including imaging, even if initial laboratory tests are normal.
Key Takeaways
- Fatigue is one of the most common presenting complaints in primary care, affecting up to 25% of adults and accounting for 5 to 10% of physician visits.
- Duration-based classification (acute, subacute, chronic) guides the diagnostic approach and helps predict likely etiologies.
- The “Big Five” causes — depression, sleep disorders, lifestyle factors, medications, and common medical conditions — account for the majority of chronic fatigue cases.
- Always screen for depression (PHQ-9), assess sleep quality (consider STOP-BANG for sleep apnea), and review the medication list early in the evaluation.
- Red flags requiring urgent evaluation include unintentional weight loss, fever, night sweats, lymphadenopathy, new neurological symptoms, and suicidal ideation.
- Baseline laboratory workup for unexplained fatigue should include complete blood count, comprehensive metabolic panel, thyroid-stimulating hormone, and inflammatory markers.
- A normal physical examination does not exclude significant pathology; many common causes of fatigue (depression, thyroid disease, sleep apnea) present with unremarkable examinations.
- Post-exertional malaise — symptom worsening 24 to 72 hours after activity — is the hallmark feature of myalgic encephalomyelitis/chronic fatigue syndrome and should be specifically asked about.
- Fatigue often has multiple overlapping causes; treating one identified cause may not resolve symptoms if additional causes remain unaddressed.
- Empiric treatment trials (iron, vitamin D, antidepressants) can serve as both diagnostic and therapeutic tools when initial workup is unrevealing.
- Myalgic encephalomyelitis/chronic fatigue syndrome is a diagnosis of exclusion requiring at least 6 months of symptoms and exclusion of other medical and psychiatric causes.
- Multidisciplinary management involving primary care, psychiatry, sleep medicine, and physical therapy may be needed for refractory cases.
Quick Reference Algorithm
Systematic Approach to Fatigue:
- Assess urgency: Check for red flags (weight loss, fever, neurological symptoms, suicidal ideation); if present, pursue urgent evaluation
- Classify by duration: Acute (less than 1 month), subacute (1 to 6 months), or chronic (greater than 6 months) — this guides the differential and workup intensity
- Take a comprehensive history: Use the “TIRED” mnemonic — Timeline/Triggers, Impact/Intensity, Rest/Recovery, Emotional/Energy, Diet/Drugs/Disease
- Screen for the Big Five: Depression (PHQ-9), sleep disorders (STOP-BANG, Epworth), lifestyle factors, medications, and common medical conditions
- Perform targeted examination: Vital signs with orthostatics, thyroid, lymph nodes, heart, lungs, and neurological examination
- Order baseline investigations: Complete blood count, comprehensive metabolic panel, thyroid-stimulating hormone, inflammatory markers; add second-tier tests based on clinical suspicion
- Treat identified causes: Address all contributing factors; many patients have multiple overlapping causes
- Reassess and adjust: If not improving, verify compliance, reconsider the diagnosis, check for additional causes, and consider specialist referral
- Consider myalgic encephalomyelitis/chronic fatigue syndrome: If symptoms persist beyond 6 months with post-exertional malaise and unrefreshing sleep, and other causes are excluded, apply diagnostic criteria and focus on symptom management
- Provide ongoing support: Fatigue can be chronic and disabling; establish a therapeutic alliance, schedule regular follow-up, and validate the patient’s experience